Haleon - Multiplikator nilai perusahaan marang pendapatan HLN

Simbol resmi perusahaan Haleon (HLN)

Haleon plc relies on years of brand trust, which creates a stable cash flow. The company's products address the fundamental hygiene and health needs of billions of people. The EV/Sales ratio confirms this resilience, with the current level standing at 3317.64. However, business success is based on demand seasonality, raw material prices, and customer loyalty.

haleon.com (HLN): Rasio nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

HLN (Haleon): rincian analitis lan laporan miturut indikator

- rega saham lan prakiraan rega para ahli:
Analisis wiwitan perusahaan:Haleon plc - HLN
Sampel barang haleon.com

The current enterprise value-to-revenue valuation confirms the status of Haleon plc (HLN) as a defensive asset within the consumer health sector. This metric compares the total business value to annual turnover, excluding the impact of leverage to identify the actual market premium. Given the steady demand for over-the-counter medications, the low volatility of this ratio signals the fundamental strength of the issuer's position.

Analisis pesaing Haleon plc

Multiplikator nilai perusahaan marang pendapatan kenvue.com|Verona Pharma (VRNA) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Jyong Biotech Limited (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Amneal Pharmaceuticals Inc AMRX|Multiplikator EV/Sales PRGO|Koefisien nilai perusahaan marang pendapatan ALVO|Multiplikator EV/Sales LQDA (Liquidia Technologies)|Multiplikator EV/Sales Galapagos GLPG|ANI Pharmaceuticals Inc - Multiplikator EV/Sales|MNKD (MannKind Corp.) - Rasio nilai perusahaan marang pendapatan|AMPH: Multiplikator EV/Sales|PCRX (Pacira BioSciences) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan ARS Pharmaceuticals Inc|Nilai perusahaan marang pendapatan Theravance Biopharma, Inc. (TBPH)|Nilai perusahaan marang pendapatan AQST (Aquestive Pharma)|SCPH - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales TECX (Tectonic Therapeutic, Inc.)|TNXP - Nilai perusahaan marang pendapatan|China SXT Pharmaceuticals, Inc. - Multiplikator EV/Sales|EPRX - Multiplikator EV/Sales|BHST: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan ENTX (Entera Bio)|Rasio nilai perusahaan marang pendapatan MindWalk (HYFT)|Multiplikator EV/Sales ABVC BioPharma, Inc. (ABVC)|Rasio nilai perusahaan marang pendapatan Cumberland Corp CPIX|QNTM - Nilai perusahaan marang pendapatan|FGEN - Rasio nilai perusahaan marang pendapatan|TELO - Multiplikator EV/Sales|Rani Therapeutics Inc (RANI) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan SNYR|Rasio nilai perusahaan marang pendapatan Rallybio Corp|Rasio nilai perusahaan marang pendapatan LEXX|Multiplikator EV/Sales PULM|PTHL: Nilai perusahaan marang volume dodolan|Multiplikator EV/Sales APM (Aptorum Group Ltd)|LYRA - Nilai perusahaan marang pendapatan|Impact BioMedical Inc - Multiplikator EV/Sales|Nilai perusahaan marang volume dodolan TNFA|YCBD (cbdmd.com) - Nilai perusahaan marang pendapatan|painreform.com - Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan CYTO|Rasio nilai perusahaan marang pendapatan LIPO|Rasio nilai perusahaan marang pendapatan optinose.com (OPTN)|PIRS (Pieris Pharma) - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Procaps Group S.A. PROC|Rasio total nilai perusahaan marang pendapatan petrospharma.com (PTPI)|QLI - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan SLRN (ACELYRIN)|TFF Pharmaceuticals, Inc (TFFP) - Rasio nilai perusahaan marang pendapatan